Hypofractionation: What Does It Mean for Prostate Cancer Treatment?

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 1, 2010, Pages 260-268

  Liao, Yixiang ^a   Joiner, Michael ^b   Huang, Yimei ^c   Burmeister, Jay ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

gEUD2; Hypofractionation; NTCP; P+; TCP

Indexed keywords

ANATOMICAL STRUCTURES; EQUIVALENT UNIFORM DOSE; EXPLORATORY STUDIES; HYPOFRACTIONATION; LINEAR-QUADRATIC MODELS; NORMAL TISSUE COMPLICATION PROBABILITIES; PROSTATE CANCERS; PROSTATE CARCINOMA; SAMPLE SETS; SIMILAR ANALYSIS; SURVIVING FRACTIONS; TUMOR CELLS; TUMOR CONTROL PROBABILITY;

PROBABILITY; STANDARDS; TRANSMISSION CONTROL PROTOCOL;

TUMORS;

ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOFRACTIONATION RADIOTHERAPY; PARAMETER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE;

ALGORITHMS; CELL SURVIVAL; DOSE FRACTIONATION; HUMANS; LINEAR MODELS; MALE; PROBABILITY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOBIOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; RELATIVE BIOLOGICAL EFFECTIVENESS; URINARY BLADDER;

EID: 72049115490     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.043     Document Type: Article

References (26)

1. Fowler J.F., Nahum A.E., and Orton C.G. Point/counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation. Med Phys 33 (2006) 3081-3084
2. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 52 (2002) 6-13
3. Wang J.Z., Guerrero M., and Li X.A. How low is the α/β ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 55 (2003) 194-203
4. Fowler J., Chappell R., and Ritter M. Is α/β for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
5. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
6. Williams S.G., Taylor J.M., Liu N., et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 24-33
7. Dasu A. Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?. Clin Oncol (R Coll Radiol) 19 (2007) 289-301
8. Nahum A.E., Movsas B., Horwitz E.M., et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio. Int J Radiat Oncol Biol Phys 57 (2003) 391-401
9. Algan O., Stobbe C.C., Helt A.M., et al. Radiation inactivation of human prostate cancer cells: The role of apoptosis. Radiat Res 146 (1996) 267-275
10. DeWeese T.L., Shipman J.M., Dillehay L.E., et al. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol 159 (1998) 591-598
11. Leith J.T., Quaranto L., Padfield G., et al. Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo. Int J Radiat Oncol Biol Phys 25 (1993) 283-287
12. Ritter M.A., Forman J.D., Kupelian P.A., et al. A Phase I/II trial of dose-per-fraction escalation for prostate cancer. Int J Radiat Oncol Biol Phys 69 (2007) S174
13. Brenner D.J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1013-1015
14. Steel G.G. Basic Clinical Radiobiology. 3rd ed. (2002), Hodder Arnold Publication, London(UK)
15. Joiner M., and Bentzen S. Time-dose relationships: The linear-quadratic approach. In: Steel G.G. (Ed). Basic clinical radiobiology. 3rd ed (2002), Hodder Arnold Publication, London(UK) 120-133
16. Niemierko A. A generalized concept of equivalent uniform dose (EUD) (Abstract). Med Phys 26 (1999) 1100
17. Wu Q., Mohan R., Niemierko A., et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52 (2002) 224-235
18. Wu Q., Djajaputra D., Liu H.H., et al. Dose sculpting with generalized equivalent uniform dose. Med Phys 32 (2005) 1387-1396
19. Song W.Y., Wong E., Bauman G.S., et al. Dosimetric evaluation of daily rigid and nonrigid geometric correction strategies during on-line image-guided radiation therapy (IGRT) of prostate cancer. Med Phys 34 (2007) 352-365
20. Woynarowska B.A., Roberts K., Woynarowski J.M., et al. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells. Radiat Res 154 (2000) 429-438
21. Bromfield G.P., Meng A., Warde P., et al. Cell death in irradiated prostate epithelial cells: Role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis 6 (2003) 73-85
22. Mavroidis P., Ferreira B.C., Papanikotaou N., et al. Assessing the difference between planned and delivered intensity-modulated radiotherapy dose distributions based on radiobiological measures. Clin Oncol (R Coll Radiol) 18 (2006) 529-538
23. Kallman P., Agren A., and Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 62 (1992) 249-262
24. Tarnawski R., Widel M., and Skladowski K. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture. Int J Radiat Oncol Biol Phys 55 (2003) 1074-1081
25. Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
26. Fowler J.F., Ritter M.A., Chappell R.J., et al. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 56 (2003) 1093-1104